Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sofinnova
Biotech
Sanofi-backed Expedition lands $115M for ph. 2 COPD trial
Expedition secured an oversubscribed $115 million series B from a line-up of big-name investors to propel its lead DPP1 inhibitor through phase 2.
Marissa Russo
Aug 5, 2026 8:00am
Rebranded biotech lands $125M for rescued Galapagos assets
Apr 28, 2026 7:00am
European VCs join forces to boost regional biotech investment
Feb 12, 2026 5:00am
VC Sofinnova ropes in €650M despite 'volatile' environment
Nov 16, 2025 7:01pm
Hemab raises $157M series C for rare bleeding disorder goals
Oct 27, 2025 6:00am
Expedition resupplies for ph. 2 COPD voyage with $165M series A
Oct 9, 2025 9:50am
